METHERGINE Side Effects

5765722-9 | Hypertensive Crisis, Paraesthesia Oral
on Jun 02, 2008 Female patient from SPAIN , 50 years of age, was diagnosed with metrorrhagia and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis, paraesthesia oral. Methergine dosage: 10ml. During the same period patient was treated with NAPROXEN ^RATIOPHARM^ (500mg Daily) (View Naproxen ^ratiopharm^ Review and Naproxen ^ratiopharm^ Label ).

5751562-3 | Condition Aggravated, Pain, Postpartum Haemorrhage
Patient was taking Methergine (View Usage). Patient had the following side effects: condition aggravated, pain (What is pain?), postpartum haemorrhage on May 19, 2008 from BRAZIL Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with postpartum haemorrhage and. Methergine dosage: 0.125 Mg/day. During the same period patient was treated with ANTIALLERGIC AGENTS, EXCL CORTICOSTEROIDS (View Antiallergic Agents, Excl Corticosteroids Review and Antiallergic Agents, Excl Corticosteroids Label ), NORETHISTERONE W/ESTROGENS/ (View Norethisterone W/estrogens/ Review and Norethisterone W/estrogens/ Label ).

5740073-7 | Abdominal Pain, Blood Calcium Decreased, Bone Pain, Menstrual Disorder
Adverse event was reported on May 12, 2008 by a Female patient taking Methergine (View Usage) (Dosage: Unk, Unk) was diagnosed with menstrual disorder and. Location: BRAZIL , 46 years of age, weighting 132.3 lb, After Methergine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood calcium decreased, bone pain, menstrual disorder.

5739215-9 | Metrorrhagia, Weight Increased
on May 12, 2008 Female patient from BRAZIL , 18 years of age, was diagnosed with haemorrhage and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: metrorrhagia, weight increased. Methergine dosage: 1 Df, Q12h. During the same period patient was treated with MICROVAL (1 Df, Qd) (View Microval Review and Microval Label ). Patient was hospitalized.


5731411-X | Acidosis, Acute Respiratory Distress Syndrome, Blood Bicarbonate Decreased, Blood Ph Decreased, Cardiac Failure, Cardiac Function Test Abnormal, Cardiac Output Increased, Central Venous Pressure Increased, Chest X-ray Abnormal
on Apr 30, 2008 Female patient from JAPAN , 28 years of age, was diagnosed with anaesthesia and was treated with Methergine (View Usage). Patient had the following side effects: acidosis, acute respiratory distress syndrome, blood bicarbonate decreased, blood ph decreased, cardiac failure, cardiac function test abnormal, cardiac output increased, central venous pressure increased, chest x-ray abnormal. Methergine dosage: 0.2 Mg. During the same period patient was treated with OXYTOCIN (5 Units) (View Oxytocin Review and Oxytocin Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), DIAZEPAM (2.5 Mg) (View Diazepam Review and Diazepam Label ), FUROSEMIDE (10 Mg) (View Furosemide Review and Furosemide Label ), ROPIVACAINE (0.2 % 3 Ml/h) (View Ropivacaine Review and Ropivacaine Label ). Patient was hospitalized.

5728350-7 | Abortion Spontaneous, Dizziness, Haemorrhage, Headache, Incorrect Dose Administered
Patient was taking Methergine (View Usage). After Methergine was administered, patient had the following side effects: abortion spontaneous, dizziness (What is dizziness?), haemorrhage, headache (What is headache?), incorrect dose administered on Apr 28, 2008 from BRAZIL Additional patient health information: Female patient , 17 years of age, was diagnosed with abdominal pain (What is abdominal pain?) and. Methergine dosage: Single Dose Of 6 Tablets. During the same period patient was treated with DIPYRONE (1 Tablet) (View Dipyrone Review and Dipyrone Label ).

5727695-4 | Abdominal Pain, Intentional Overdose, Premature Separation Of Placenta, Vaginal Discharge, Vaginal Haemorrhage
Adverse event was reported on Apr 28, 2008 by a Female patient taking Methergine (View Usage) (Dosage: 12 Df) was diagnosed with abortion (What is abortion?) and. Location: BRAZIL , 24 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), intentional overdose, premature separation of placenta, vaginal discharge, vaginal haemorrhage.

5725560-X | Abortion Threatened, Metrorrhagia, Weight Increased
on Apr 24, 2008 Female patient from BRAZIL , 18 years of age, was diagnosed with haemorrhage and was treated with Methergine (View Usage). Patient had the following side effects: abortion threatened, metrorrhagia, weight increased. Methergine dosage: 1 Df, Bid. During the same period patient was treated with MICROVAL (1 Df, Qd) (View Microval Review and Microval Label ). Patient was hospitalized.

5717202-4 | Ejection Fraction Decreased, Peripartum Cardiomyopathy, Pulmonary Oedema, Ventricular Hypokinesia
on Apr 15, 2008 Female patient from JAPAN , 28 years of age, was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: ejection fraction decreased, peripartum cardiomyopathy, pulmonary oedema, ventricular hypokinesia. Methergine dosage: 0.2 Mg. During the same period patient was treated with OXYTOCIN (5 Units) (View Oxytocin Review and Oxytocin Label ).

5716176-X | Ejection Fraction Decreased, Peripartum Cardiomyopathy, Pulmonary Oedema, Ventricular Hypokinesia
Patient was taking Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: ejection fraction decreased, peripartum cardiomyopathy, pulmonary oedema, ventricular hypokinesia on Apr 15, 2008 from JAPAN Additional patient health information: Female patient , 28 years of age, . Methergine dosage: 0.2 Mg. During the same period patient was treated with OXYTOCIN (5 Units) (View Oxytocin Review and Oxytocin Label ).

5710931-8 | Abdominal Pain, Dizziness, Hallucination, Hyperhidrosis, Malaise, Vision Blurred
Adverse event was reported on Apr 14, 2008 by a Female patient taking Methergine (View Usage) (Dosage: 2 Amps/single Dose) was diagnosed with haemorrhage and. Location: BRAZIL , 38 years of age, weighting 143.3 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), hallucination, hyperhidrosis, malaise, vision blurred.

5710913-6 | Abdominal Pain, Intentional Overdose, Vaginal Discharge, Vaginal Haemorrhage
on Apr 15, 2008 Female patient from BRAZIL , 24 years of age, weighting 132.3 lb, was diagnosed with abortion (What is abortion?) and was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), intentional overdose, vaginal discharge, vaginal haemorrhage. Methergine dosage: 12 Df.

5709036-1 | Abdominal Pain, Dizziness, Hallucination, Hyperhidrosis, Malaise, Vision Blurred
on Apr 10, 2008 Female patient from BRAZIL , 38 years of age, weighting 143.3 lb, was diagnosed with haemorrhage and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), hallucination, hyperhidrosis, malaise, vision blurred. Methergine dosage: 2 Amps/single Dose.

5700150-3 | Chills
Patient was taking Methergine (View Usage). Patient had the following side effects: chills on Apr 02, 2008 from INDIA Additional patient health information: Female patient , 24 years of age, was diagnosed with labour stimulation and. Methergine dosage: 0.2 Mg/ml, Unk. During the same period patient was treated with SYNTOCINON (View Syntocinon Review and Syntocinon Label ).

5608275-8 | Abdominal Pain, Uterine Haemorrhage
Adverse event was reported on Jan 23, 2008 by a Female patient taking Methergine (View Usage) (Dosage: 6 Df, Bid) was diagnosed with abortion induced and. Location: BRAZIL , 31 years of age, After Methergine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), uterine haemorrhage.

5588019-9 | Condition Aggravated, Pain, Postpartum Haemorrhage
on Jan 02, 2008 Female patient from BRAZIL , weighting 138.9 lb, was diagnosed with postpartum haemorrhage and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, pain (What is pain?), postpartum haemorrhage. Methergine dosage: 0.125 Mg/day. During the same period patient was treated with ANTIALLERGIC AGENTS, EXCL CORTICOSTEROIDS (View Antiallergic Agents, Excl Corticosteroids Review and Antiallergic Agents, Excl Corticosteroids Label ).

5572840-7 | Abdominal Pain, Foetal Growth Retardation
on Dec 18, 2007 Female patient from BRAZIL , 23 years of age, weighting 114.6 lb, was diagnosed with uterine haemorrhage and was treated with Methergine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), foetal growth retardation. Methergine dosage: Unk, Q6h.

5456428-4 | Maculopathy, Photopsia, Reflexes Abnormal, Retinal Vascular Disorder, Scotoma, Vision Blurred
Patient was taking Methergine (View Usage). After Methergine was administered, patient had the following side effects: maculopathy, photopsia, reflexes abnormal, retinal vascular disorder, scotoma, vision blurred on Sep 11, 2007 from BELGIUM Additional patient health information: Female patient , 30 years of age, was diagnosed with hypotension and. Methergine dosage: Twice. During the same period patient was treated with ETILEFRINE (View Etilefrine Review and Etilefrine Label ).

5448267-5 | Abdominal Pain Upper, Cold Sweat, Dizziness, Dysstasia, Hyperhidrosis, Nausea, Presyncope, Tremor
Adverse event was reported on Sep 04, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.125 Mg, Tid) was diagnosed with uterine atony and. Location: BRAZIL , 24 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, cold sweat, dizziness (What is dizziness?), dysstasia, hyperhidrosis, nausea (What is nausea?), presyncope, tremor.

5441487-5 | Blood Pressure Increased, Cardiac Failure, Electrocardiogram St Segment Depression, Hypokinesia, Pneumothorax, Tachycardia, Troponin I Increased, Ventricular Hypokinesia
on Aug 27, 2007 Female patient from UNITED STATES , 18 years of age, was diagnosed with uterine atony and was treated with Methergine (View Usage). Patient had the following side effects: blood pressure increased, cardiac failure, electrocardiogram st segment depression, hypokinesia, pneumothorax, tachycardia, troponin i increased, ventricular hypokinesia. Methergine dosage: 0.2 Mg, Once/single.

5413233-2 | Abdominal Pain, Intentional Overdose, Threatened Labour
on Aug 07, 2007 Female patient from BRAZIL , 23 years of age, was diagnosed with intentional overdose, headache (What is headache?) and was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), intentional overdose, threatened labour. Methergine dosage: 1.875 Mg, Once/single. During the same period patient was treated with BUSCOPAN (30 Drp, Qd) (View Buscopan Review and Buscopan Label ).

5413213-7 | Abdominal Discomfort, Abdominal Pain, Apathy, Asthenia, Deafness Bilateral, Malaise
Patient was taking Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal pain (What is abdominal pain?), apathy, asthenia, deafness bilateral, malaise on Aug 06, 2007 from BRAZIL Additional patient health information: Female patient , 25 years of age, weighting 132.3 lb, was diagnosed with menorrhagia, contraception and. Methergine dosage: 0.125 Mg, Q8h. During the same period patient was treated with GALENIC /ESTRADIOL/NORETHISTERONE/ (View Galenic /estradiol/norethisterone/ Review and Galenic /estradiol/norethisterone/ Label ).

5376940-6 | Anaemia, Headache, Influenza, Menorrhagia, Vomiting
Adverse event was reported on Jun 19, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.125 Mg, Once/single) was diagnosed with haemorrhage and. Location: , 33 years of age, weighting 138.9 lb, Patient had the following side effects: anaemia, headache (What is headache?), influenza, menorrhagia, vomiting.

5368178-3 | Blood Pressure Increased, Cardiac Failure, Electrocardiogram St Segment Depression, Tachycardia, Ventricular Hypokinesia
on Jun 14, 2007 Female patient from UNITED STATES , 18 years of age, was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: blood pressure increased, cardiac failure, electrocardiogram st segment depression, tachycardia, ventricular hypokinesia. Methergine dosage: 0.2 Mg, Unk.

5360204-0 | Abortion Spontaneous, Uterine Contractions During Pregnancy
on Jun 06, 2007 Female patient from BRAZIL , weighting 140.0 lb, was diagnosed with haemorrhage, pain (What is pain?) and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, uterine contractions during pregnancy. Methergine dosage: 0.125 Mg, Unk. During the same period patient was treated with BUSCOPAN (View Buscopan Review and Buscopan Label ). Patient was hospitalized.

5357240-7 | Hypoaesthesia, Nail Bed Tenderness, Vasoconstriction
Patient was taking Methergine (View Usage). Patient had the following side effects: hypoaesthesia, nail bed tenderness, vasoconstriction on Jun 12, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 209.0 lb, was diagnosed with migraine (What is migraine?) and. Methergine dosage: One 0.2 Mg Tablet Daily Po.

5323352-7 | Abortion Missed, Headache, Malaise
Adverse event was reported on May 02, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.125 Mg, Bid) was diagnosed with haemorrhage and. Location: BRAZIL , 17 years of age, weighting 105.8 lb, After Methergine was administered, patient had the following side effects: abortion missed, headache (What is headache?), malaise.

5323342-4 | Abortion Missed, Headache, Malaise
on May 02, 2007 Female patient from BRAZIL , 17 years of age, weighting 105.8 lb, was diagnosed with haemorrhage and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion missed, headache (What is headache?), malaise. Methergine dosage: 0.125 Mg, Bid.

5322707-4 | Abortion Missed, Headache, Malaise
on May 02, 2007 Female patient from BRAZIL , 17 years of age, weighting 105.8 lb, was diagnosed with haemorrhage and was treated with Methergine (View Usage). Patient had the following side effects: abortion missed, headache (What is headache?), malaise. Methergine dosage: 0.125 Mg, Bid.

5289165-X | Accidental Exposure, Hypotension, Lethargy
Patient was taking Methergine (View Usage). After Methergine was administered, patient had the following side effects: accidental exposure, hypotension, lethargy on Oct 23, 2002 from UNITED STATES Additional patient health information: Female patient , child 2 years of age, weighting 29.98 lb, . Methergine dosage: 1.2 Mg, Once/single, Oral. Patient was hospitalized.

5277072-8 | Paraesthesia, Sensation Of Heaviness
Adverse event was reported on Mar 13, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.2 Mg/ml, Tid) . Location: VENEZUELA , 27 years of age, Patient experienced the following unwanted or unexpected effects: paraesthesia, sensation of heaviness. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

5257762-3 | Condition Aggravated, Uterine Contractions Abnormal, Uterine Haemorrhage
on Feb 23, 2007 Female patient from BRAZIL , 34 years of age, weighting 138.9 lb, was diagnosed with uterine haemorrhage, dysmenorrhoea and was treated with Methergine (View Usage). Patient had the following side effects: condition aggravated, uterine contractions abnormal, uterine haemorrhage. Methergine dosage: 0.125 Mg, Q8h. During the same period patient was treated with PONSTAN (1 Df, Q8h) (View Ponstan Review and Ponstan Label ).

5257761-1 | Dyspnoea, Fatigue, Feeling Abnormal, Haemorrhage
on Feb 23, 2007 Female patient from BRAZIL , 29 years of age, weighting 154.3 lb, was diagnosed with contraception, haemorrhage and was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: dyspnoea, fatigue, feeling abnormal, haemorrhage. Methergine dosage: 1 Amp A Month.

5245081-0 | Hypertension, Malaise, Paraesthesia, Tachycardia
Patient was taking Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, malaise, paraesthesia, tachycardia on Feb 19, 2007 from FRANCE Additional patient health information: Female patient , 35 years of age, was diagnosed with post abortion haemorrhage and. Methergine dosage: 15 Drp, Tid.

5244063-2 | Condition Aggravated, Postpartum Haemorrhage
Adverse event was reported on Feb 09, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.125 Mg, Qd) was diagnosed with postpartum haemorrhage and. Location: BRAZIL , 25 years of age, weighting 167.6 lb, Patient had the following side effects: condition aggravated, postpartum haemorrhage.

5240456-8 | Headache, Insomnia, Nausea, Syncope
on Feb 05, 2007 Female patient from BRAZIL , 18 years of age, weighting 99.21 lb, was diagnosed with menstrual disorder and was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: headache (What is headache?), insomnia, nausea (What is nausea?), syncope. Methergine dosage: 0.125 Mg, Tid.

5223738-5 | Blood Pressure Immeasurable, Body Temperature Decreased, Body Temperature Increased, Complication Of Delivery, Cyanosis, Dyspnoea, Mental Impairment, Oxygen Saturation Decreased, Pallor
on Jan 17, 2007 Female patient from UNITED STATES , 39 years of age, weighting 146.0 lb, was diagnosed with postpartum haemorrhage, vaginal haemorrhage, prophylaxis and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure immeasurable, body temperature decreased, body temperature increased, complication of delivery, cyanosis, dyspnoea, mental impairment, oxygen saturation decreased, pallor. Methergine dosage: 0.2 Mg, Once/single. During the same period patient was treated with CYTOTEC (600 Mcg Once) (View Cytotec Review and Cytotec Label ), OXYTOCIN (Unk, Unk) (View Oxytocin Review and Oxytocin Label ), PENICILLIN G (5 Million Units X 1) (View Penicillin G Review and Penicillin G Label ). Patient was hospitalized.

5223737-3 | Blood Pressure Increased, Body Temperature Increased, Complication Of Delivery, Cyanosis, Dyspnoea, Headache, Oxygen Saturation Decreased, Postpartum Sepsis, Tachycardia
Patient was taking Methergine (View Usage). Patient had the following side effects: blood pressure increased, body temperature increased, complication of delivery, cyanosis, dyspnoea, headache (What is headache?), oxygen saturation decreased, postpartum sepsis, tachycardia on Jan 17, 2007 from UNITED STATES Additional patient health information: Female patient , 25 years of age, weighting 173.9 lb, was diagnosed with postpartum haemorrhage, sepsis (What is sepsis?) and. Methergine dosage: 0.2 Mg, Once/single. During the same period patient was treated with UNASYN (3 G, Q6h) (View Unasyn Review and Unasyn Label ). Patient was hospitalized.

5218982-7 | Body Temperature Increased, Chills, Complication Of Delivery, Cyanosis, Dyspnoea, Livedo Reticularis, Tachycardia
Adverse event was reported on Jan 17, 2007 by a Female patient taking Methergine (View Usage) (Dosage: 0.2 Mg, Once/single) was diagnosed with postpartum haemorrhage and. Location: UNITED STATES , 29 years of age, weighting 143.0 lb, After Methergine was administered, patient had the following side effects: body temperature increased, chills, complication of delivery, cyanosis, dyspnoea, livedo reticularis, tachycardia. During the same period patient was treated with CYTOTEC (800 Mcg X 1) (View Cytotec Review and Cytotec Label ). Patient was hospitalized.

5175453-4 | Rash Papular
on Dec 04, 2006 Female patient from ITALY , 32 years of age, was diagnosed with caesarean section and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: rash papular. Methergine dosage: 60 Drops/day. Patient was hospitalized.

5121653-9 | Burning Sensation, Hypersensitivity, Pruritus, Rash, Skin Exfoliation
on Sep 22, 2006 Female patient from BRAZIL , 32 years of age, was diagnosed with haemorrhage, hypothyroidism and was treated with Methergine (View Usage). Patient had the following side effects: burning sensation, hypersensitivity, pruritus, rash (What is rash?), skin exfoliation. Methergine dosage: 0.125 Mg, Q8h. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5108767-4 | Anxiety, Arrhythmia, Discomfort, Hallucination
Patient was taking Methergine (View Usage). After Methergine was administered, patient had the following side effects: anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), discomfort, hallucination on Sep 07, 2006 from DENMARK Additional patient health information: Female patient , 41 years of age, weighting 136.7 lb, was diagnosed with vaginal haemorrhage and. Methergine dosage: .

5078473-3 | Haemorrhage, Hyperhidrosis, Malaise, Tremor, Vomiting
Adverse event was reported on Aug 01, 2006 by a Female patient taking Methergine (View Usage) (Dosage: ) was diagnosed with menstrual disorder and. Location: BRAZIL , 42 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: haemorrhage, hyperhidrosis, malaise, tremor, vomiting.

5063517-5 | Haemorrhage
on Jul 19, 2006 Female patient from BRAZIL , 22 years of age, was treated with Methergine (View Usage). Patient had the following side effects: haemorrhage. Methergine dosage: .

5044097-7 | Convulsion Neonatal, Feeding Disorder Neonatal
on Jun 26, 2006 Female patient from FRANCE , weighting 7.72 lb, was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: convulsion neonatal, feeding disorder neonatal. Methergine dosage: 0.125 Mg, Tid. Patient was hospitalized.

5024186-3 | Angiopathy, Cerebral Disorder, Cerebrovascular Spasm, Grand Mal Convulsion, Haemorrhage, Headache, Loss Of Consciousness, Nuclear Magnetic Resonance Imaging Abnormal, Postpartum Disorder
Patient was taking Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: angiopathy, cerebral disorder, cerebrovascular spasm, grand mal convulsion, haemorrhage, headache (What is headache?), loss of consciousness, nuclear magnetic resonance imaging abnormal, postpartum disorder on May 24, 2006 from JAPAN Additional patient health information: Female patient , 28 years of age, . Methergine dosage: 0.25 Mg/day. During the same period patient was treated with OXYTOCIN (5 Iu/h, Unk) (View Oxytocin Review and Oxytocin Label ). Patient was hospitalized.

5021484-4 | Angiopathy, Cerebrovascular Spasm, Grand Mal Convulsion, Haemorrhage, Headache, Loss Of Consciousness, Nuclear Magnetic Resonance Imaging Abnormal, Visual Disturbance
Adverse event was reported on May 24, 2006 by a Female patient taking Methergine (View Usage) (Dosage: 0.25 Mg/day) . Location: JAPAN , 28 years of age, Patient had the following side effects: angiopathy, cerebrovascular spasm, grand mal convulsion, haemorrhage, headache (What is headache?), loss of consciousness, nuclear magnetic resonance imaging abnormal, visual disturbance. During the same period patient was treated with OXYTOCIN (5 Iu/h, Unk) (View Oxytocin Review and Oxytocin Label ). Patient was hospitalized.

5019454-5 | Angiopathy, Cerebrovascular Spasm, Grand Mal Convulsion, Headache, Loss Of Consciousness, Nuclear Magnetic Resonance Imaging Abnormal, Visual Disturbance
on May 24, 2006 Female patient from JAPAN , 28 years of age, was treated with Methergine (View Usage). After Methergine was administered, patient had the following side effects: angiopathy, cerebrovascular spasm, grand mal convulsion, headache (What is headache?), loss of consciousness, nuclear magnetic resonance imaging abnormal, visual disturbance. Methergine dosage: 0.25 Mg/day.

5010529-3 | Accidental Overdose, Malaise
on May 19, 2006 Female patient from FRANCE , 35 years of age, was diagnosed with metrorrhagia and was treated with Methergine (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, malaise. Methergine dosage: 200 Drp, Once/single.

4951763-8 | Depressed Mood, Intentional Overdose, Nervousness
Patient was taking Methergine (View Usage). Patient had the following side effects: depressed mood, intentional overdose, nervousness on Mar 14, 2006 from BRAZIL Additional patient health information: Female patient , 27 years of age, weighting 156.5 lb, was diagnosed with uterine haemorrhage and. Methergine dosage: 0.125 Mg, Qd.